辰欣药业：股东韩延振已减持2.365%

Core Viewpoint - The announcement from Chenxin Pharmaceutical indicates that shareholder Han Yanzhen plans to reduce his stake by up to 13.58 million shares, representing 3% of the total shares held [1] Shareholder Reduction Plan - Han Yanzhen originally held 31.9778 million shares, which accounted for 7.06% of the total shares [1] - As of November 26, 2025, Han Yanzhen has already reduced his holdings by 6.1993 million shares through block trading and 4.5092 million shares through centralized bidding, totaling 10.7085 million shares, or 2.365% of the total shares [1] - After the planned reduction, Han Yanzhen and his concerted action party, Jiangsu Chenxing Tongtai Enterprise Management Co., Ltd., will hold a combined total of 22.6376 million shares, representing 4.999% of the total shares [1]